Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Pediatrics|April 17, 1998
A pilot study of combination therapy with indinavir, stavudine (d4T), and didanosine (ddI) in children infected with the human immunodeficiency virusM W Kline, C V Fletcher, A T Harris, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavirT N Kakuda, L M Page, P L Anderson, et al.
AIDS (London, England)|January 11, 2000
Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV- infected subjects: ACTG 884C V Fletcher, E P Acosta, H Cheng, et al.
Clinical Pharmacology and Therapeutics|October 29, 2010
Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivoJ Chen, R C Garner, L S Lee, et al.
Transplantation|January 11, 1991
Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovirD L Dunn, J L Mayoral, K J Gillingham, et al.
The Pediatric Infectious Disease Journal|July 24, 2001
Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infectionM W Kline, R C Brundage, C V Fletcher, et al.
HIV Medicine|May 12, 2015
Pharmacokinetics of tenofovir during pregnancy and postpartumB M Best, S Burchett, H Li, et al.
The Journal of Infectious Diseases|July 7, 2000
Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adultsJ M Jacobson, I Lowy, C V Fletcher, et al.
The Journal of Antimicrobial Chemotherapy|November 26, 2020
Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB preventionA T Podany, J Leon-Cruz, J Hakim, et al.
Pediatrics|April 2, 1999
A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 TeamM W Kline, S Blanchard, C V Fletcher, et al.
Pageof 8